BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 37813358)

  • 21. Long-term follow-up of elite controllers: Higher risk of complications with HCV coinfection, no association with HIV disease progression.
    Stafford KA; Rikhtegaran Tehrani Z; Saadat S; Ebadi M; Redfield RR; Sajadi MM
    Medicine (Baltimore); 2017 Jun; 96(26):e7348. PubMed ID: 28658155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Platelet Polymorphism can be a genetic marker associated with HIV/HCV coinfection.
    Grotto RM; Picelli N; de Souza Ldo R; Silva GF; Ferrasi AC; Silveira LV; Pardini MI
    J Med Virol; 2015 Oct; 87(10):1677-81. PubMed ID: 25976501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
    May MT; Justice AC; Birnie K; Ingle SM; Smit C; Smith C; Neau D; Guiguet M; Schwarze-Zander C; Moreno S; Guest JL; Monforte Ad; Tural C; Gill MJ; Bregenzer A; Kirk O; Saag M; Sterling TR; Crane HM; Sterne JA
    J Acquir Immune Defic Syndr; 2015 Jul; 69(3):348-54. PubMed ID: 25848927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PROFILE OF HCV GENOTYPES AND HIV-SUBTYPES AMONG HIV-COINFECTED PATIENTS IN SOUTHERN BRAZIL.
    Silva CMD; Peder LD; Thomazella MV; Teixeira JJV; Bertolini DA
    Arq Gastroenterol; 2019; 56(4):344-350. PubMed ID: 31800733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantification of hepatic FOXP3+ T-lymphocytes in HIV/hepatitis C coinfection.
    Williams SK; Donaldson E; Van der Kleij T; Dixon L; Fisher M; Tibble J; Gilleece Y; Klenerman P; Banham AH; Howard M; Webster DP
    J Viral Hepat; 2014 Apr; 21(4):251-9. PubMed ID: 24597693
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals.
    Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM;
    Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatitis C virus coinfection independently increases the risk of cardiovascular disease in HIV-positive patients.
    Fernández-Montero JV; Barreiro P; de Mendoza C; Labarga P; Soriano V
    J Viral Hepat; 2016 Jan; 23(1):47-52. PubMed ID: 26390144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower liver-related death in African-American women with human immunodeficiency virus/hepatitis C virus coinfection, compared to Caucasian and Hispanic women.
    Sarkar M; Bacchetti P; French AL; Tien P; Glesby MJ; Nowicki M; Plankey M; Gange S; Sharp G; Minkoff H; Peters MG;
    Hepatology; 2012 Nov; 56(5):1699-705. PubMed ID: 22618868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reasons to include the serology of human T-lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) in the clinical follow-up of patients with viral hepatitis B and C in Brazil.
    Campos KR; Alves FA; Lemos MF; Moreira RC; Marcusso RMN; Caterino-de-Araujo A
    PLoS Negl Trop Dis; 2020 May; 14(5):e0008245. PubMed ID: 32453768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Liver enzyme elevation during darunavir-based antiretroviral treatment in HIV-1-infected patients with or without hepatitis C coinfection: data from the ICONA foundation cohort.
    Di Biagio A; Nicolini LA; Lorenzini P; Puoti M; Antinori A; Cozzi-Lepri A; Gori A; Vecchiet J; Mussini C; Andreoni M; Viscoli C; d'Arminio Monforte A; For The Icona Foundation Study Group
    HIV Clin Trials; 2014; 15(4):151-60. PubMed ID: 25143024
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients.
    Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V
    Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
    Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
    J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997.
    van der Helm J; Geskus R; Sabin C; Meyer L; Del Amo J; Chêne G; Dorrucci M; Muga R; Porter K; Prins M;
    Gastroenterology; 2013 Apr; 144(4):751-760.e2. PubMed ID: 23266560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of HIV viral control on the incidence of hepatocellular carcinoma in veterans with hepatitis C and HIV coinfection.
    Kramer JR; Kowalkowski MA; Duan Z; Chiao EY
    J Acquir Immune Defic Syndr; 2015 Apr; 68(4):456-62. PubMed ID: 25559606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis C virus-HIV-coinfected patients and liver transplantation.
    Kardashian AA; Price JC
    Curr Opin Organ Transplant; 2015 Jun; 20(3):276-85. PubMed ID: 25944240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study.
    Seyoum E; Demissie M; Worku A; Mihret A; Abdissa A; Berhane Y
    BMC Public Health; 2022 Apr; 22(1):644. PubMed ID: 35379215
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV.
    Limketkai BN; Mehta SH; Sutcliffe CG; Higgins YM; Torbenson MS; Brinkley SC; Moore RD; Thomas DL; Sulkowski MS
    JAMA; 2012 Jul; 308(4):370-8. PubMed ID: 22820790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
    Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
    Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV coinfection and antiretroviral therapy enhances liver steatosis in patients with hepatitis C, but only in those infected by HCV genotype other than 3.
    Borghi V; Puoti M; Mussini C; Bellelli S; Angeletti C; Sabbatini F; Prati F; Cossarizza A; Esposito R
    Antivir Ther; 2008; 13(8):1057-65. PubMed ID: 19195331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.
    Abruzzi A; Fried B; Alikhan SB
    Adv Parasitol; 2016; 91():111-231. PubMed ID: 27015949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.